Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06475261
What this trial is testing

Tissue Oximetry's Measurement in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy

Who this might be right for
Oxygen DeficiencyAcute Kidney InjuryOvarian Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Testing effectiveness (Phase 2)UnknownNCT04846842
What this trial is testing

Oral Gimatecan in Platinum-Resistant Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Lee's Pharmaceutical Limited 46
Early research (Phase 1)Looking for participantsNCT07116486
What this trial is testing

A Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
M.D. Anderson Cancer Center 60
Not applicableEnded earlyNCT01954173
What this trial is testing

Adjuvant Radiation for High Risk Bladder Cancer

Who this might be right for
Bladder CancerSquamous Cell Carcinoma of the BladderStage III Bladder Cancer+2 more
Emory University 19
Very early researchNot Yet RecruitingNCT06752473
What this trial is testing

KSD-101 Therapy for Standard Treatment Failed EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial

Who this might be right for
Nasopharyngeal Carcinoma (NPC)EBV
Kousai Bio Co., Ltd. 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04069273
What this trial is testing

Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma

Who this might be right for
Gastric CancerGastroEsophageal CancerAdenocarcinoma
Harry H Yoon 58
Very early researchLooking for participantsNCT07067905
What this trial is testing

Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma and Glioblastoma
Chinese PLA General Hospital 15
Early research (Phase 1)Study completedNCT01837329
What this trial is testing

Phase I Study of Tetrathiomolybdate in Combination With Carboplatin/Pemetrexed in Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
University of Rochester 26
Not applicableStudy completedNCT02848872
What this trial is testing

Evaluation of Tumor and Blood Immune Biomarkers in Resected Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Carcinoma
Duke University 25
Large-scale testing (Phase 3)Active Not RecruitingNCT06462001
What this trial is testing

BCG + MMC: Adding Mitomycin C to BCG in High-risk, Non-muscle-invasive Bladder Cancer

Who this might be right for
Transitional Cell CarcinomaTransurethral Resection
Nottingham University Hospitals NHS Trust 500
Not applicableUnknownNCT04966130
What this trial is testing

Effect of Urinary Indwelling Time on Early Continence After Robot-assisted Radical Cystectomy With Orthotopic Ileal Neobladder.

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT04074967
What this trial is testing

Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab

Who this might be right for
Renal Cell CarcinomaMelanomaSolid Tumor+2 more
Dan Zandberg 70
Not applicableStudy completedNCT01401907
What this trial is testing

Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies

Who this might be right for
Non-small Cell Lung CancerSmall Cell Lung CancerMesothelioma+4 more
Massachusetts General Hospital 351
Early research (Phase 1)Study completedNCT02555007
What this trial is testing

Metronomic Chemotherapy Based on Adaptative Bio-mathematical Model of Oral Vinorelbine in Patients With NSCLC or MPM

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)Malignant Pleural Mesothelioma (MPM)
Assistance Publique Hopitaux De Marseille 30
Large-scale testing (Phase 3)Looking for participantsNCT02448992
What this trial is testing

Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer (NSCLC)Brain Metastasis
Chang Gung Memorial Hospital 90
Early research (Phase 1)Study completedNCT02387307
What this trial is testing

RSIFN-co in Subjects With Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Renal CellMelanoma+2 more
Sichuan Huiyang Life Science and Technology Corporation 42
Not applicableUnknownNCT05671900
What this trial is testing

Gemcitabine and Docetaxel Therapy in High-risk BCG-naive Patients With Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder Cancer
Clinical Hospital Centre Zagreb 70
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Not applicableWithdrawnNCT02817607
What this trial is testing

Study to Assess Breast Sensation Before and After Breast Cancer Treatment

Who this might be right for
Breast ReconstructionDuctal Carcinoma In-situ
Duke University
Testing effectiveness (Phase 2)Study completedNCT03890731
What this trial is testing

A Clinical Study of Regorafenib in Participants Who Have Been Treated in Previous Bayer-sponsored Regorafenib Studies That Have Been Completed

Who this might be right for
Solid Cancer
Bayer 6
Next Page